Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels.

[1]  E. Berry,et al.  Preferential metabolism by macrophages of conditioned rabbit hypercholesterolemic remnant lipoproteins. , 1988, Biochimica et biophysica acta.

[2]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Ooshima,et al.  Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. B. Zilversmit,et al.  Influx, Efflux, and Hydrolysis of Cholesteryln Ester in Atheromatous Lesionsd of Cholesterol‐Fed Rabbit , 1986, Arteriosclerosis.

[5]  M. Tomikawa,et al.  Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit. , 1986, Japanese journal of pharmacology.

[6]  R. Dworski,et al.  Dietary Supplementation with Vitamin E in Hyperlipoproteinemias: Effects on Plasma Lipid Peroxides, Antioxidant Activity, Prostacyclin Generation and Platelet Aggregability , 1985, Thrombosis and Haemostasis.

[7]  T. Carew,et al.  A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. , 1984, Journal of lipid research.

[8]  F. Bernini,et al.  Effects of probucol on the in vivo plasma clearance of human low density lipoproteins in rabbits and on the expression of lipoprotein receptors in vitro. , 1984, Atherosclerosis.

[9]  S. Grundy,et al.  Influence of probucol on cholesterol and lipoprotein metabolism in man. , 1984, Journal of lipid research.

[10]  J. Loeper,et al.  [Fatty acids and lipid peroxidation in experimental atheroma in the rabbit. Role played by silicon]. , 1984, Pathologie-biologie.

[11]  Y. Matsuzawa,et al.  Effects of probucol on homozygous cases of familial hypercholesterolemia. , 1983, Atherosclerosis.

[12]  C. Packard,et al.  The hypolipidemic action of probucol: a study of its effects on high and low density lipoproteins. , 1983, Journal of lipid research.

[13]  R. Havel,et al.  Concentration and Composition of Lipoproteins in Blood Plasma of the WHHL Rabbit , 1982, Arteriosclerosis.

[14]  B. Lewis,et al.  The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia. , 1982, Atherosclerosis.

[15]  B. Joffe,et al.  Treatment of homozygous familial hypercholesterolaemia with probucol. , 1982, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[16]  O. Stein,et al.  Use of 3H‐Cholesteryl Linoleyl Ether for the Quantitation of Plasma Cholesteryi Ester Influx into the Aortic Wall in Hypercholesterolemic Rabbits , 1982, Arteriosclerosis.

[17]  Marshall Fn.  Pharmacology and toxicology of probucol. , 1982 .

[18]  T. Strandberg,et al.  Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the rat. , 1981, Atherosclerosis.

[19]  L. Simons,et al.  On the mechanism of plasma cholesterol reduction in the rat given probucol. , 1981, Clinical science.

[20]  A. J. Valente,et al.  Properties of apolipoprotein B in urea and in aqueous buffers. The use of glutathione and nitrogen in its solubilization. , 1981, Biochimica et biophysica acta.

[21]  P. Nestel,et al.  Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis. , 1981, Atherosclerosis.

[22]  S. Gatt,et al.  The synthesis of cholesteryl alkyl ethers , 1980, Steroids.

[23]  H. Shigematsu,et al.  A xerographic method for the quantitative assessment of atherosclerotic lesions. , 1978, Atherosclerosis.

[24]  K. Yagi,et al.  A simple fluorometric assay for lipoperoxide in blood plasma. , 1976, Biochemical medicine.

[25]  A. Kuksis,et al.  Determination of plasma lipid profiles by automated gas chromatography and computerized data analysis. , 1975, Journal of chromatographic science.

[26]  P. McCay,et al.  Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. , 1973, The Journal of biological chemistry.

[27]  D. Kritchevsky,et al.  Influence of 4,4'-(Isopropylidenedithio)bis(2,6-di-t-butylphenol) (DH-581) on Experimental Atherosclerosis in Rabbits 1 , 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[28]  J. W. Barnhart,et al.  Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol). , 1970, The American journal of clinical nutrition.

[29]  V. Dole.  A relation between non-esterified fatty acids in plasma and the metabolism of glucose. , 1956, The Journal of clinical investigation.

[30]  W. Stoll.  Eine neue Darstellungsweise von Cholesterinäthern. , 1932 .